Entropy Technologies LP Takes $369,000 Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Entropy Technologies LP purchased a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,562 shares of the company’s stock, valued at approximately $369,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Champlain Investment Partners LLC lifted its holdings in shares of Ryan Specialty by 28.0% in the 1st quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company’s stock worth $274,022,000 after acquiring an additional 1,079,505 shares during the last quarter. Principal Financial Group Inc. raised its position in Ryan Specialty by 148.9% in the 3rd quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after purchasing an additional 509,548 shares during the period. Bessemer Group Inc. lifted its stake in Ryan Specialty by 33.9% in the first quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company’s stock worth $106,886,000 after purchasing an additional 488,067 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Ryan Specialty by 132.2% during the second quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company’s stock valued at $48,425,000 after buying an additional 476,126 shares during the period. Finally, 2Xideas AG bought a new position in shares of Ryan Specialty during the first quarter valued at approximately $19,765,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Price Performance

Shares of RYAN opened at $70.94 on Friday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a 50 day moving average price of $68.28 and a 200-day moving average price of $61.82. Ryan Specialty Holdings, Inc. has a fifty-two week low of $41.49 and a fifty-two week high of $73.10. The stock has a market capitalization of $18.58 billion, a PE ratio of 92.13, a PEG ratio of 1.63 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same quarter in the prior year, the business earned $0.32 earnings per share. Ryan Specialty’s revenue was up 20.5% on a year-over-year basis. Equities analysts predict that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th will be paid a $0.11 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.62%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on RYAN. Barclays initiated coverage on Ryan Specialty in a report on Wednesday, September 4th. They set an “overweight” rating and a $76.00 price objective for the company. UBS Group boosted their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a research note on Tuesday, August 13th. The Goldman Sachs Group raised their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 9th. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. Finally, Bank of America raised their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Ryan Specialty has an average rating of “Hold” and a consensus price target of $70.33.

Insiders Place Their Bets

In other news, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the sale, the executive vice president now owns 12,386 shares of the company’s stock, valued at $884,236.54. This trade represents a 54.42 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 2,325 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $64.60, for a total value of $150,195.00. Following the transaction, the director now owns 3,463 shares in the company, valued at approximately $223,709.80. This trade represents a 40.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 94,193 shares of company stock worth $6,208,493. 11.10% of the stock is owned by corporate insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.